Official US Government Icon

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Secure Site Icon

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

The latest general information on the Coronavirus Disease 2019 (COVID-19) is available on For USDOT specific COVID-19 resources, please visit our page.

DOT Rule 49 CFR Part 40 Section 40.199

Subpart I—Problems in Drug Tests

§ 40.199 What problems always cause a drug test to be cancelled?
(a) As the MRO, when the laboratory discovers a “fatal flaw” during its processing of incoming specimens (see §40.83), the laboratory will report to you that the specimen has been “Rejected for Testing” (with the reason stated). You must always cancel such a test.

(b) The following are “fatal flaws”:

     (1)  There is no CCF;

     (2)  In cases where a specimen has been collected, there is no specimen submitted with the CCF;

     (3)  There is no printed collector's name and no collector's signature;

     (4)  Two separate collections are performed using one CCF;

     (5)  The specimen ID numbers on the specimen bottle and the CCF do not match;

     (6)  The specimen bottle seal is broken or shows evidence of tampering (and a split specimen cannot be re-designated, see §40.83(h)); or

     (7)  Because of leakage or other causes, there is an insufficient amount of urine in the primary specimen bottle for analysis and the specimens cannot be re-designated (see §40.83(h))
[as amended 82 FR 52246, November 13, 2017]
Last updated: Monday, January 1, 2018